Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Frontiers in Genetics
|
April 19, 2024
Stigma associated with genetic testing for rare diseases-causes and recommendations
Gareth Baynam, Roy Gomez, Ritu Jain
JMIR Research Protocols
|
June 6, 2025
Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study
Yen-Hung Lin, Hsu-Wen Chou, Sarah Tsai, et al.
Annales D'Endocrinologie
|
March 27, 2019
Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy
Odile Basmaison, Bruno Ranchin, Hichem Zouater, et al.
Frontiers in Pediatrics
|
September 7, 2021
Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004-2015)
Tal Ben-Ari, Gabriel Chodick, Varda Shalev, et al.
Frontiers in Endocrinology
|
March 18, 2022
Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review
Roy Gomez, S Faisal Ahmed, Mohamad Maghnie, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
May 8, 2024
<i>Post hoc</i> subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin
Roy Gomez, Vaman Khadilkar, Jayashri Shembalkar, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
November 21, 2025
Comparing the efficacy and safety of weekly somatrogon with daily somatropin in Asian children living with growth hormone deficiency: a plain language summary of publication
Roy Gomez, Vaman Khadilkar, Jayashri Shembalkar, et al.
Frontiers in Endocrinology
|
November 13, 2023
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
Roy Gomez, Roger Lamoureux, Diane M Turner-Bowker, et al.
Clinical Endocrinology
|
October 27, 2015
A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study
Jean De Schepper, Johan Vanderfaeillie, Primus-E Mullis, et al.
Pituitary
|
January 13, 2022
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience
Roberto Salvatori, Pietro Maffei, Susan M Webb, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Frontiers in Genetics
|
April 19, 2024
Stigma associated with genetic testing for rare diseases-causes and recommendations
Gareth Baynam, Roy Gomez, Ritu Jain
JMIR Research Protocols
|
June 6, 2025
Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study
Yen-Hung Lin, Hsu-Wen Chou, Sarah Tsai, et al.
Annales D'Endocrinologie
|
March 27, 2019
Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy
Odile Basmaison, Bruno Ranchin, Hichem Zouater, et al.
Frontiers in Pediatrics
|
September 7, 2021
Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004-2015)
Tal Ben-Ari, Gabriel Chodick, Varda Shalev, et al.
Frontiers in Endocrinology
|
March 18, 2022
Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review
Roy Gomez, S Faisal Ahmed, Mohamad Maghnie, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
May 8, 2024
<i>Post hoc</i> subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin
Roy Gomez, Vaman Khadilkar, Jayashri Shembalkar, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
November 21, 2025
Comparing the efficacy and safety of weekly somatrogon with daily somatropin in Asian children living with growth hormone deficiency: a plain language summary of publication
Roy Gomez, Vaman Khadilkar, Jayashri Shembalkar, et al.
Frontiers in Endocrinology
|
November 13, 2023
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
Roy Gomez, Roger Lamoureux, Diane M Turner-Bowker, et al.
Clinical Endocrinology
|
October 27, 2015
A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study
Jean De Schepper, Johan Vanderfaeillie, Primus-E Mullis, et al.
Pituitary
|
January 13, 2022
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience
Roberto Salvatori, Pietro Maffei, Susan M Webb, et al.
Page
of 3